Location History:
- Cambridge, MA (US) (2002)
- Princeton, NJ (US) (2003)
Company Filing History:
Years Active: 2002-2003
Title: Innovations of Jennifer Chee
Introduction
Jennifer Chee is an accomplished inventor based in Princeton, NJ. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that target potassium channels and chemokine receptors. With a total of two patents to her name, her work is paving the way for advancements in treating various medical conditions.
Latest Patents
Jennifer's latest patents include "Carbocyclic potassium channel inhibitors," which relate to a class of carbocyclic compounds that are useful as potassium channel inhibitors. These compounds have potential applications in treating autoimmune disorders and cardiac arrhythmias. Another notable patent is "4-alkyl piperidinyl pyrrolidine modulators of chemokine receptor activity," which focuses on modulating chemokine receptor activity for therapeutic purposes.
Career Highlights
Jennifer Chee is currently employed at Merck & Company, Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her work is characterized by a commitment to developing effective treatments that address critical health issues.
Collaborations
Jennifer collaborates with esteemed colleagues, including Frank Kayser and William H. Parsons, who share her dedication to advancing medical science through innovative research.
Conclusion
Jennifer Chee's contributions to the field of pharmacology through her patents and collaborations highlight her role as a leading inventor in the industry. Her work is instrumental in the ongoing quest for effective medical treatments.